Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

126.85
+1.331.06%
Pre-market: 127.670.8200+0.65%04:01 EDT
Volume:1.29M
Turnover:163.16M
Market Cap:8.35B
PE:-56.90
High:129.28
Open:121.66
Low:120.19
Close:125.52
52wk High:155.44
52wk Low:23.30
Shares:65.83M
Float Shares:64.65M
Volume Ratio:0.86
T/O Rate:1.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2293
EPS(LYR):-1.2987
ROE:-29.59%
ROA:-13.09%
PB:18.73
PE(LYR):-97.68

Loading ...

Twist Bioscience Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 04

Twist Bioscience Outlook FY Revenue USD 442-447 Million

THOMSON REUTERS
·
May 04

Twist Bioscience FY26 Q2 net loss widens to $44 million; revenue rises 19% to $110.7 million

Reuters
·
May 04

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal Q3 Revenue Range $114M to $115M, vs. FactSet Est of $111.3M

MT Newswires Live
·
May 04

Earnings Flash (TWST) Twist Bioscience Posts Fiscal Q2 Loss $0.71 a Share, vs. FactSet Est of $0.50 Loss

MT Newswires Live
·
May 04

Twist Bioscience posts fiscal 2026 Q2 earnings report, investor presentation online

Reuters
·
May 04

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

THOMSON REUTERS
·
May 04

Twist Bioscience Corp Outlook Q3 Total Revenue of Approximately $114 Million to $115 Million

THOMSON REUTERS
·
May 04

Twist Bioscience Corp Q3 REV View $111.4 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
May 04

Twist Bioscience director Melissa Starovasnik sells 500 shares worth $30,915

Reuters
·
Apr 30

Earning Preview: Twist Bioscience Corp revenue expected to increase by 17.03% this quarter, and institutional views are bullish

Earnings Agent
·
Apr 27

Twist Bio CFO Adam Laponis disposes of 4,000 shares worth $240,000

Reuters
·
Apr 22

Press Release: Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

Dow Jones
·
Apr 21

Twist Bioscience CFO Adam Laponis sells 3,000 shares worth $165,000

Reuters
·
Apr 17

Twist Bioscience Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

CORRECTED-Amazon launches AI research tool to speed early-stage drug discovery

Reuters
·
Apr 14

Twist Bioscience Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Apr 07

Twist Bioscience Director Melissa Starovasnik sells USD 51 million common shares

Reuters
·
Apr 04

Twist Bioscience Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 30

Twist Bioscience price target raised to $55 from $50 at Guggenheim

TIPRANKS
·
Mar 30